Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in June 2019

August 2019 in “ Regenerative Medicine ”

Dusko Ilic, Mirjana Liovic, Laila Noli

TLDR In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

In June 2019, there were numerous advancements in stem cell research and regenerative medicine. Follica reported positive interim data from a study on male androgenetic alopecia, showing significant hair count improvement in 20 male participants. Minovia Therapeutics began a Phase I/II trial for Pearson syndrome with 7 pediatric patients, and the FDA granted several designations to their mitochondrial cell therapy. Triumvira Immunologics received approval for a Phase I/II study of TAC01-CD19, a T-cell therapy for B-cell malignancies. Kiadis Pharma acquired CytoSen Therapeutics to enhance cell-based cancer immunotherapy. GPB Scientific was awarded a $2.2 million NIH grant to improve cell separation technology, and InGeneron extended its Series D financing to $43 million for cell therapy programs. Additionally, various strategic collaborations, clinical trials, and regulatory designations were announced, reflecting significant progress in the field.

View this study on futuremedicine.com →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research The Genetically Programmed Hair Growth Cycle And Alopecia: What Is There To Know?

3 citations, June 2006 in “Expert Review of Dermatology”

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

research Clinical Updates in Hair

19 citations, January 1997 in “Dermatologic Clinics”

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

research Alopecia: The Search for Novel Agents Continues

11 citations, August 1997 in “Expert Opinion on Therapeutic Patents”

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

research The Placebo Effect And Randomized Trials: Analysis Of Conventional Medicine

26 citations, February 2002 in “Urologic clinics of North America”

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

research Comparison of a New 5% Minoxidil Foam and Rogaine in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial

January 2023 in “Dermatologic Therapy”

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

research Five-Year Follow-Up of Men with Androgenetic Alopecia Treated with Topical Minoxidil

70 citations, April 1990 in “Journal of The American Academy of Dermatology”

Minoxidil treatment increased hair growth for up to 5 years, requiring twice daily application.

Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in June 2019

Related Community Posts Join

community Hair Loss Drugs Ranked in Order of Efficacy

community What else is good. Besides the big 3.

community Comparison of styled hair, similar haircut 9 months apart. (Oral Fin/Topical Min/Microneedling)

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

community Androgenetic alopecia - I want your honest opinion

community My scalp punch biopsy results🤔?